An observational study in ENT Outpatient Conditions, sponsored by AlFayhaa General Hospital. Not yet recruiting at 2 sites in Iraq. Per ClinicalTrials.gov, last updated 2026-11-03.
Sponsored by AlFayhaa General Hospital · Observational
This cross-sectional, observational study evaluates drug utilization patterns and prescribing practices in the ear, nose, and throat (ENT) outpatient department using World Health Organization (WHO) core prescribing indicators. The study aims to assess prescription quality, the average number of drugs per encounter, antibiotic overuse, generic prescribing rates, and adherence to essential medicines lists to promote rational drug use and identify potential polypharmacy trends.
AlFayhaa General Hospital is the lead sponsor of 6 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients of any age group attending the Ear, Nose, and Throat (ENT) outpatient department and receiving at least one medical prescription during the study period.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Prescriptions issued to patients attending the ear, nose, and throat (ENT) outpatient department during the study period.
Average Number of Drugs Per Prescription
Assessment of the average number of medications prescribed per patient encounter in the ENT outpatient department using WHO prescribing indicators.
Time frame: During the 4-6 month study period
Percentage of Encounters with Antibiotics
To calculate the percentage of patient encounters where at least one antibiotic is prescribed in the ENT outpatient department.
Time frame: During the 4-6 month study period
Percentage of Drugs Prescribed by Generic Name
To assess the extent of generic prescribing relative to total drugs prescribed in the ENT outpatient department.
Time frame: During the 4-6 month study period
Adherence to Essential Medicines List
To evaluate whether the prescribed medications are selected from the official essential medicines list.
Time frame: During the 4-6 month study period
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
AlFayhaa General Hospital